The global demand for Endoscopic Retrograde Cholangiopancreatography Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Endoscopic retrograde cholangio pancreatography refers to the clinical procedure used for the diagnosis and treatment of the liver, ball ducts and pancreas etc. It is a minimally invasive intervention procedure which combines upper gastrointestinal endoscopy and x-rays for the treatment of different gastrointestinal conditions. During endoscopic retrograde cholangio pancreatography, the doctor locates the opening of bile pancreas ducts where it empties into the duodenum, slides a catheter into the ducts, inserts a contrast medium into the ducts for more visibility of the ducts and uses fluoroscopy for the examination of blockages. But, there can be bloating and nausea after the procedure.
Market Dynamics
The rising cancer cases is the main factor driving the demand for the endoscopic retrograde cholangio pancreatography market. The rise in the generic population, along with the growing prevalence of biliary disorders, is surging the demand for this market. The increasing development of healthcare infrastructure in developing countries is propelling the demand for this market. Moreover, the rising preference for minimally invasive surgeries is upsurging the demand for the endoscopic retrograde cholangio pancreatography market. Rising cases of pancreatic duct and bile duct stones are augmenting the demand for this market. Furthermore, increasing government initiative and rising investment by healthcare organizations to enhance endoscopy research is expanding the demand for this market. The growth in medical tourism is boosting the demand for this market.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of endoscopic retrograde cholangiopancreatography. The growth and trends of endoscopic retrograde cholangiopancreatography industry provide a holistic approach to this study.
Market Segmentation
This section of the endoscopic retrograde cholangiopancreatography market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
- Endoscopes
- Endotherapy Devices (Sphincterotome, Lithotripter, Stents, Cannulas, Forceps, Snares, Catheters, Guiding Wires, Balloons, Baskets, Others)
- Imaging Devices
- Energy Devices
- Others
By Application
- Biliary Sphincterotomy
- Biliary Dilatation
- Biliary Stenting
- Pancreatic Sphincterotomy
- Pancreatic Duct Dilatation
- Pancreatic Duct Stenting
By End User
- Hospitals & Clinics
- Ambulatory Surgery Centers
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Endoscopic Retrograde Cholangiopancreatography market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Endoscopic Retrograde Cholangiopancreatography Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the endoscopic retrograde cholangiopancreatography market include Olympus Corporation, Conmed Corporation, Hobbs Medical, Inc., TeleMed Systems, Inc., Boston Scientific Corporation, Cook Group Incorporation, Ambu, Inc., Becton, Dickinson and Company, Fujifilm Holding Corporation, and Medtronic Plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By End User
3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET ANALYSIS BY PRODUCT TYPE
6.1 Overview by Product Type
6.2 Historical and Forecast Data
6.3 Analysis by Product Type
6.4 Endoscopes Historic and Forecast Sales by Regions
6.5 Endotherapy Devices (Sphincterotome, Lithotripter, Stents, Cannulas, Forceps, Snares, Catheters, Guiding Wires, Balloons, Baskets, Others) Historic and Forecast Sales by Regions
6.6 Imaging Devices Historic and Forecast Sales by Regions
6.7 Energy Devices Historic and Forecast Sales by Regions
6.8 Others Historic and Forecast Sales by Regions
7 . GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET ANALYSIS BY APPLICATION
7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Biliary Sphincterotomy Historic and Forecast Sales by Regions
7.5 Biliary Dilatation Historic and Forecast Sales by Regions
7.6 Biliary Stenting Historic and Forecast Sales by Regions
7.7 Pancreatic Sphincterotomy Historic and Forecast Sales by Regions
7.8 Pancreatic Duct Dilatation Historic and Forecast Sales by Regions
7.9 Pancreatic Duct Stenting Historic and Forecast Sales by Regions
8 . GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SALES ANALYSIS BY END USER
8.1 Overview by End User
8.2 Historical and Forecast Data
8.3 Analysis by End User
8.4 Hospitals & Clinics Historic and Forecast Sales by Regions
8.5 Ambulatory Surgery Centers Historic and Forecast Sales by Regions
8.6 Others Historic and Forecast Sales by Regions
9 . GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SALES ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
9.3.1. Overview, Historic and Forecast Sales Analysis
9.3.2. North America By Segment Sales Analysis
9.3.3. North America By Country Sales Analysis
9.3.4. United State Sales Analysis
9.3.5. Canada Sales Analysis
9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
9.4.1. Overview, Historic and Forecast Sales Analysis
9.4.2. Europe by Segment Sales Analysis
9.4.3. Europe by Country Sales Analysis
9.4.4. United Kingdom Sales Analysis
9.4.5. France Sales Analysis
9.4.6. Germany Sales Analysis
9.4.7. Italy Sales Analysis
9.4.8. Russia Sales Analysis
9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
9.5.1. Overview, Historic and Forecast Sales Analysis
9.5.2. Asia Pacific by Segment Sales Analysis
9.5.3. Asia Pacific by Country Sales Analysis
9.5.4. China Sales Analysis
9.5.5. India Sales Analysis
9.5.6. Japan Sales Analysis
9.5.7. South Korea Sales Analysis
9.5.8. Australia Sales Analysis
9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
9.6.1. Overview, Historic and Forecast Sales Analysis
9.6.2. Latin America by Segment Sales Analysis
9.6.3. Latin America by Country Sales Analysis
9.6.4. Brazil Sales Analysis
9.6.5. Argentina Sales Analysis
9.6.6. Peru Sales Analysis
9.6.7. Chile Sales Analysis
9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
9.7.1. Overview, Historic and Forecast Sales Analysis
9.7.2. Middle East & Africa by Segment Sales Analysis
9.7.3. Middle East & Africa by Country Sales Analysis
9.7.4. Saudi Arabia Sales Analysis
9.7.5. UAE Sales Analysis
9.7.6. Israel Sales Analysis
9.7.7. South Africa Sales Analysis
9.7.8. Rest Of Middle East And Africa Sales Analysis
10 . COMPETITIVE LANDSCAPE OF THE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY COMPANIES
10.1. Endoscopic Retrograde Cholangiopancreatography Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11 . COMPANY PROFILES OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY INDUSTRY
11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Olympus Corporation
11.3.1. Company Overview
11.3.2. Company Revenue
11.3.3. Products
11.3.4. Recent Developments
11.4. Conmed Corporation
11.4.1. Company Overview
11.4.2. Company Revenue
11.4.3. Products
11.4.4. Recent Developments
11.5. Hobbs Medical Inc.
11.5.1. Company Overview
11.5.2. Company Revenue
11.5.3. Products
11.5.4. Recent Developments
11.6. TeleMed Systems Inc.
11.6.1. Company Overview
11.6.2. Company Revenue
11.6.3. Products
11.6.4. Recent Developments
11.7. Boston Scientific Corporation
11.7.1. Company Overview
11.7.2. Company Revenue
11.7.3. Products
11.7.4. Recent Developments
11.8. Cook Group Incorporation
11.8.1. Company Overview
11.8.2. Company Revenue
11.8.3. Products
11.8.4. Recent Developments
11.9. Ambu Inc.
11.9.1. Company Overview
11.9.2. Company Revenue
11.9.3. Products
11.9.4. Recent Developments
11.10. Becton
11.10.1. Company Overview
11.10.2. Company Revenue
11.10.3. Products
11.10.4. Recent Developments
11.11. Dickinson and Company
11.11.1. Company Overview
11.11.2. Company Revenue
11.11.3. Products
11.11.4. Recent Developments
11.12. Fujifilm Holding Corporation
11.12.1. Company Overview
11.12.2. Company Revenue
11.12.3. Products
11.12.4. Recent Developments
11.13. Medtronic Plc.
11.13.1. Company Overview
11.13.2. Company Revenue
11.13.3. Products
11.13.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Product Type (USD MN)
- Endoscopes Market Sales by Geography (USD MN)
- Endotherapy Devices (Sphincterotome, Lithotripter, Stents, Cannulas, Forceps, Snares, Catheters, Guiding Wires, Balloons, Baskets, Others) Market Sales by Geography (USD MN)
- Imaging Devices Market Sales by Geography (USD MN)
- Energy Devices Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis Market by Application (USD MN)
- Biliary Sphincterotomy Market Sales by Geography (USD MN)
- Biliary Dilatation Market Sales by Geography (USD MN)
- Biliary Stenting Market Sales by Geography (USD MN)
- Pancreatic Sphincterotomy Market Sales by Geography (USD MN)
- Pancreatic Duct Dilatation Market Sales by Geography (USD MN)
- Pancreatic Duct Stenting Market Sales by Geography (USD MN)
- Analysis by End User (USD MN)
- Hospitals & Clinics Market Sales by Geography (USD MN)
- Ambulatory Surgery Centers Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Endoscopic Retrograde Cholangiopancreatography Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Endoscopic Retrograde Cholangiopancreatography Report
- Market Research Process
- Market Research Methodology
- Global Endoscopic Retrograde Cholangiopancreatography Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Product Type
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by End User
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Product Type (USD MN)
- Endoscopes Market Sales by Geography (USD MN)
- Endotherapy Devices (Sphincterotome, Lithotripter, Stents, Cannulas, Forceps, Snares, Catheters, Guiding Wires, Balloons, Baskets, Others) Market Sales by Geography (USD MN)
- Imaging Devices Market Sales by Geography (USD MN)
- Energy Devices Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Biliary Sphincterotomy Market Sales by Geography (USD MN)
- Biliary Dilatation Market Sales by Geography (USD MN)
- Biliary Stenting Market Sales by Geography (USD MN)
- Pancreatic Sphincterotomy Market Sales by Geography (USD MN)
- Pancreatic Duct Dilatation Market Sales by Geography (USD MN)
- Pancreatic Duct Stenting Market Sales by Geography (USD MN)
- Global Market Analysis by End User (USD MN)
- Hospitals & Clinics Market Sales by Geography (USD MN)
- Ambulatory Surgery Centers Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Company Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.